Furthermore, osteosarcoma patients with lower protein expression of both AHA1 and IDH1 exhibited better prognosis (Fig. 6d, e), even though the difference of disease-free survival were not statistically significant due to the inadequate number of cases. This evidence concerns the gene IDH1 and osteosarcoma.